Patanase and Adcirca drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Patanase (olopatadine hydrochloride) and Adcirca (tadalafil). Common drug interactions include fall among females and bacterial infection among males.
The phase IV clinical study analyzes what interactions people have when they take Patanase and Adcirca. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.
What is Patanase?
Patanase has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 1,514 Patanase users. Check the latest studies of Patanase.
What is Adcirca?
Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.
20 people who take Patanase and Adcirca together, and have interactions are studied.

What are the common drug interactions of Patanase and Adcirca, by gender? *:
female:
- Fall
- Injury
- Pneumonia respiratory syncytial viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children)
- Radius fracture
- Wrist fracture
- Asthma
- Cardiac failure congestive
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Diabetic foot
- Diabetic foot infection
male:
- Bacterial infection
- Salmonellosis (an infection with salmonella bacteria)
- Influenza
- Pneumonia
- Sinusitis (inflammation of sinus)
- Weight decreased
- Asthenia (weakness)
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
- Epistaxis (bleed from the nose)
- Haematuria (presence of blood in urine)
What are the common drug interactions of Patanase and Adcirca, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Pneumonia respiratory syncytial viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children)
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
- Epistaxis (bleed from the nose)
- Haematuria (presence of blood in urine)
- Pulmonary embolism (blockage of the main artery of the lung)
60+:
- Fall
- Injury
- Rectal haemorrhage (bleeding from anus)
- Renal failure acute (rapid kidney dysfunction)
- Sinusitis (inflammation of sinus)
- Wrist fracture
- Cardiac failure congestive
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Diabetic foot
- Diabetic foot infection
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 7 people, 35.00%
- Multiple Myeloma (cancer of the plasma cells): 6 people, 30.00%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 15.00%
- Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 10.00%
- Asthma: 2 people, 10.00%
- Stress And Anxiety: 1 person, 5.00%
- Nausea And Vomiting: 1 person, 5.00%
- Nausea (feeling of having an urge to vomit): 1 person, 5.00%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.00%
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Patanase and Adcirca?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Patanase and Adcirca:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Patanase:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Adcirca:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Patanase and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Adcirca and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on olopatadine hydrochloride and tadalafil (the active ingredients of Patanase and Adcirca, respectively), and Patanase and Adcirca (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Loratadine and Xolair drug interactions for women aged 30-39 - a second ago
- Propecia vs. Spironolactone, side effect and effectiveness comparison - 3 seconds ago
- Chromium Picolinate vs. Fluoxetine, side effect and effectiveness comparison - 8 seconds ago
- Sandimmune and Renal Failure Acute for Women aged 50-59 - 8 seconds ago
- Sandimmune and Renal Failure for Women aged 50-59 - 8 seconds ago
- Sandimmune and Kidney Failure for Women aged 50-59 - 9 seconds ago
- Sandimmune and Arf for Women aged 50-59 - 9 seconds ago
- Sandimmune and Acute Kidney Failure for Women aged 50-59 - 9 seconds ago
- Could Spiriva cause Abdominal Pain Lower? - 19 seconds ago
- Drug interactions of Diphenhydramine Hydrochloride and Linagliptin - 21 seconds ago